607 related articles for article (PubMed ID: 23852952)
1. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.
Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V
J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
4. Generation, translocation, and presentation of MHC class I-restricted peptides.
Heemels MT; Ploegh H
Annu Rev Biochem; 1995; 64():463-91. PubMed ID: 7574490
[TBL] [Abstract][Full Text] [Related]
5. Functional regulation of immunoproteasomes and transporter associated with antigen processing.
Hwang LY; Lieu PT; Peterson PA; Yang Y
Immunol Res; 2001; 24(3):245-72. PubMed ID: 11817324
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
[TBL] [Abstract][Full Text] [Related]
7. The peptide-loading complex--antigen translocation and MHC class I loading.
Schölz C; Tampé R
Biol Chem; 2009 Aug; 390(8):783-94. PubMed ID: 19426129
[TBL] [Abstract][Full Text] [Related]
8. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
[TBL] [Abstract][Full Text] [Related]
9. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
[TBL] [Abstract][Full Text] [Related]
10. In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
Hoves S; Aigner M; Pfeiffer C; Laumer M; Obermann EC; Mackensen A
Leukemia; 2009 May; 23(5):877-85. PubMed ID: 19148137
[TBL] [Abstract][Full Text] [Related]
11. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.
Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A
Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary and functional perspectives of the major histocompatibility complex class I antigen-processing machinery.
Paulsson KM
Cell Mol Life Sci; 2004 Oct; 61(19-20):2446-60. PubMed ID: 15526153
[TBL] [Abstract][Full Text] [Related]
13. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
14. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival.
Lou Y; Basha G; Seipp RP; Cai B; Chen SS; Moise AR; Jeffries AP; Gopaul RS; Vitalis TZ; Jefferies WA
Clin Cancer Res; 2008 Mar; 14(5):1494-501. PubMed ID: 18316574
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells.
Russ G; Ramachandra M; Hrycyna CA; Gottesman MM; Pastan I; Bennink JR; Yewdell JW
Cancer Res; 1998 Oct; 58(20):4688-93. PubMed ID: 9788623
[TBL] [Abstract][Full Text] [Related]
16. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
[TBL] [Abstract][Full Text] [Related]
17. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
[TBL] [Abstract][Full Text] [Related]
18. Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?
Garbi N; Tanaka S; van den Broek M; Momburg F; Hämmerling GJ
Immunol Rev; 2005 Oct; 207():77-88. PubMed ID: 16181328
[TBL] [Abstract][Full Text] [Related]
19. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
[TBL] [Abstract][Full Text] [Related]
20. Different regulation of MHC class I antigen processing components in human tumors.
Seliger B
J Immunotoxicol; 2008 Oct; 5(4):361-7. PubMed ID: 19404870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
